Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOSTARLIMAB vs DOSTARLIMAB-GXLY: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOSTARLIMAB vs DOSTARLIMAB-GXLY: Safety Overview

Metric DOSTARLIMAB DOSTARLIMAB-GXLY
Total FAERS Reports 893 504
Deaths Reported 130 55
Death Rate 14.6% 10.9%
Hospitalizations 441 126
Average Patient Age 65.8 yrs 67.4 yrs
% Female Patients 91.6% 92.7%
Manufacturer GlaxoSmithKline LLC N/A
Route INTRAVENOUS N/A
Marketing Status N/A Prescription